finder.com
US
AU
NZ
UK
CA
SG
More

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Abcam stock

Own Abcam stock in just a few minutes.

Jing Jun Ma
Jing Jun Ma

Updated . What changed?

Fact checked
Buy Abcam (ABCM) Learn more

Abcam plc is a biotechnology business based in the US. Abcam shares (ABCM) are listed on the NASDAQ and all prices are listed in US Dollars. Abcam employs 1,492 staff and has a market cap (total outstanding shares value) of USD$5.3 billion.

How to buy shares in Abcam

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Abcam. Find the stock by name or ticker symbol: ABCM. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Abcam reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Abcam, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Abcam. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

What's in this guide?

  1. ABCM shares summary
  2. Compare share dealing platforms
  3. Is ABCM stock a buy or sell?
  4. Stock performance over time
  5. Can I short ABCM shares?
  6. Are ABCM shares over-valued?
  7. Abcam's financials
  8. How volatile are ABCM shares?
  9. Does Abcam pay a dividend?
  10. Other common questions

Abcam share price

Use our graph to track the performance of ABCM stocks over time.

Abcam shares at a glance

Information last updated 2021-02-24.
52-week rangeUSD$17.71 - USD$24.69
50-day moving average USD$22.7676
200-day moving average USD$20.7611
Wall St. target priceUSD$1636.24
PE ratio 240.0243
Dividend yield USD$0.15 (0.66%)
Earnings per share (TTM) N/A

Buy Abcam shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
$0
Stocks, Options, ETFs, Gold/Commodities
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Go to site
More Info
Interactive Brokers
Interactive Brokers
$0
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
0%
N/A
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Go to site
More Info
Tastyworks
Tastyworks
$0
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Go to site
More Info
Moomoo
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
N/A
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
Go to site
More Info
TradeStation
TradeStation
$0
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Go to site
More Info
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Abcam stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Abcam plc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Abcam under- or over-valued?

Valuing Abcam stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Abcam's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Abcam's P/E ratio

Abcam's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 240x. In other words, Abcam shares trade at around 240x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

However, Abcam's P/E ratio is best considered in relation to those of others within the biotechnology industry or those of similar companies.

Abcam financials

Gross profit TTM USD$180.2 million
Return on assets TTM 4.42%
Return on equity TTM 2.82%
Profit margin 4.81%
Book value N/A
Market capitalisation USD$5.3 billion

TTM: trailing 12 months

Shorting Abcam shares

There are currently 243,603 Abcam shares held short by investors – that's known as Abcam's "short interest". This figure is 1.4% up from 240,320 last month.

There are a few different ways that this level of interest in shorting Abcam shares can be evaluated.

Abcam's "short interest ratio" (SIR)

Abcam's "short interest ratio" (SIR) is the quantity of Abcam shares currently shorted divided by the average quantity of Abcam shares traded daily (recently around 243603). Abcam's SIR currently stands at 1. In other words for every 100,000 Abcam shares traded daily on the market, roughly 1000 shares are currently held short.

To gain some more context, you can compare Abcam's short interest ratio against those of similar companies.

However Abcam's short interest can also be evaluated against the total number of Abcam shares, or, against the total number of tradable Abcam shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Abcam's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Abcam shares in existence, roughly 0 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Abcam shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Abcam.

Find out more about how you can short Abcam stock.

Abcam share dividends

Dividend payout ratio: 202.68% of net profits

Recently Abcam has paid out, on average, around 202.68% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.66% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Abcam shareholders could enjoy a 0.66% return on their shares, in the form of dividend payments. In Abcam's case, that would currently equate to about $0.15 per share.

Abcam's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 19 March 2020 (the "ex-dividend date").

Abcam's dividend payout ratio is perhaps best considered in relation to those of similar companies.

Abcam share price volatility

Over the last 12 months, Abcam's shares have ranged in value from as little as $17.71 up to $24.69. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Abcam's is 0.4005. This would suggest that Abcam's shares are less volatile than average (for this exchange).

To put Abcam's beta into context you can compare it against those of similar companies.

Abcam overview

Abcam plc, a life sciences company, researches, develops, and distributes biological reagents and tools for research, drug discovery, and diagnostics in the United States, China, Japan, Europe, the Middle East, Africa, and rest of Asia Pacific. The company offers various research products, including primary and secondary antibodies; ELISA and matched antibody pairs; cell and tissue imaging tools; cellular and biochemical assays; proteins and peptides; proteomics tools; agonists, antagonists, activators, and inhibitors; lysates; and multiplex assays. Its research products are used in the areas of cancer, cardiovascular, cell biology, developmental biology, epigenetics, nuclear signaling, immunology, metabolism, microbiology, neuroscience, signal transduction, and stem cells. Further, the company offers diagnostic and therapeutic solutions. The company also sells its products online. Abcam plc was founded in 1998 and is headquartered in Cambridge, the United Kingdom.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site